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Abstract
Background: The reported diagnostic yield from bronchoscopies in patients with lung cancer
varies greatly. The optimal combination of sampling techniques has not been finally established.
The objectives of this study were to find the predictors of diagnostic yield in bronchoscopy and to
evaluate different combinations of sampling techniques.
Methods: All bronchoscopies performed on suspicion of lung malignancy in 2003 and 2004 were
reviewed, and 363 patients with proven malignant lung disease were included in the study. Sampling
techniques performed were biopsy, transbronchial needle aspiration (TBNA), brushing, small
volume lavage (SVL), and aspiration of fluid from the entire procedure. Logistic regression analyses
were adjusted for sex, age, endobronchial visibility, localization (lobe), distance from carina, and
tumor size.
Results: The adjusted odds ratios (OR) with 95% confidence intervals (CI) for a positive diagnostic
yield through all procedures were 17.0 (8.5–34.0) for endobronchial lesions, and 2.6 (1.3–5.2) for
constriction/compression, compared to non-visible lesions; 3.8 (1.3–10.7) for lesions > 4 cm, 6.7
(2.1–21.8) for lesions 3–4 cm, and 2.5 (0.8–7.9) for lesions 2–3 cm compared with lesions <= 2 cm.
The combined diagnostic yield of biopsy and TBNA was 83.7% for endobronchial lesions and 54.2%
for the combined group without visible lesions. This was superior to either technique alone,
whereas additional brushing, SVL, and aspiration did not significantly increase the diagnostic yield.
Conclusion: In patients with malignant lung disease, visible lesions and larger tumor size were
significant predictors of higher diagnostic yield, after adjustment for sex, age, distance from carina,
side and lobe. The combined diagnostic yield of biopsy and TBNA was significant higher than with
either technique alone.
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Background
The incidence of lung cancer in Norway increased from
21.1/100 000 person years in 1967–1971 to 36.1/100 000
in 2000–2004 for men and from 4.5/100 000 to 21.1/100
000 for women [1]. Bronchoscopy is the main diagnostic
procedure in patients with endoscopic visible lesions.
British Thoracic Society (BTS) guidelines from 2001 rec-
ommend biopsies, brushings, and washings for sampling
from visible lesions. The diagnostic yield for visible
lesions should be at least 80% [2]. Transbronchial needle
aspiration (TBNA) was not included in the recommenda-
tion, and the optimal combination of sampling tech-
niques in peripheral lesions was not settled [2].
Computer tomography (CT) guided sampling techniques
have a diagnostic yield of approximately 90% in periph-
eral lung cancer [3], with the disadvantage of a high inci-
dence of pneumothorax [4]. Previous studies of
bronchoscopy in peripheral lesions have shown a great
variability in the diagnostic yield, with sensitivity for can-
cer between 20% and 86% [5-9]. The reported predictors
of positive samples have been size [6,9-16], location
[10,13,14,17], visible lesion, compression or constriction
[12,18,19], CT bronchus sign [13,17,20], fuzzy or sharp
border [11], the use of a C-arm fluoroscope [8,21], and
sampling technique [11,14,15,18,22-29]. Many studies
were based on bronchoscopies performed by selected
investigators in highly specialized centres [5,8,10,18].
The great variability in the previous studies makes it diffi-
cult to know if the real life situation in a clinical practice
is comparable with the reported results. The choice of
sampling techniques is often left to the physician who
performs the bronchoscopy, and it is not known if a
standardised approach gives better results.
The aims of this study were to evaluate the sensitivity of
bronchoscopy for detecting malignant disease in clinical
practice, identify predictors of a high diagnostic yield, and
to evaluate different pairs of sampling techniques.
Methods
All 1438 bronchoscopies performed between January
2003 and December 2004 at Haukeland University Hos-
pital, Bergen, Norway, were retrospectively reviewed. All
procedures where the indication for bronchoscopy was to
obtain samples from a lesion suspicious of malignancy
and where the final diagnosis obtained through all possi-
ble methods was malignant lung disease were eligible for
inclusion in the study. If a patient had repeated broncho-
scopies, only the first bronchoscopy was included.
Of 493 patients with a lesion suspicious of malignancy,
367 patients were investigated with bronchoscopy of later
proven malignant disease. Three patients were excluded
because no samplings had been performed during bron-
choscopy, and one patient was excluded because it was
not possible to perform the bronchoscopy. Thus, 363
patients were included in the study sample.
Twenty three medical doctors; nine pulmonologists and
fourteen trainees (pulmonary residents and fellows) per-
formed the bronchoscopies. The investigations were per-
formed with Olympus BF 1T 160 bronchoscopes, using
Boston "Radial Jaw3" for biopsies, Boston 21 Gauche
"Stifcor" transbronchial aspiration needle for TBNA, and
Boston "Cellebrity" for brushings. TBNA was taken
directly from endobronchial lesions, under visual control
from constriction and compression, and blind or under
fluoroscopic guidance from peripheral lesions. The proce-
dures were performed transorally without an endotra-
cheal tube. Patients were semi-sedated with pethidine
hydrochloride 25–75 mg or midazolam 2.5–5 mg. Biop-
sies and small volume lavage (SVL), a bronchial washing
with 10–20 ml saline were fixated in formalin. TBNA and
brushings were alcohol fixed on a glass slide. In addition,
aspiration from the whole bronchoscopy was collected
and a sample of 10–20 ml was fixated in formalin.
Two of the authors (KR and TME) registered endobron-
chial visibility and indications for bronchoscopy based on
a review of the bronchoscopy reports. Endobronchial vis-
ibility was categorized into 1) visible lesion, 2) constriction,
compression or suspected submucosal changes, or 3) non-visible
lesion. The largest size of the lesion was measured from the
CT scan in all but five cases, in which size was estimated
from the chest radiograph. The distance from carina to the
lesion was measured on a posterior-anterior chest radio-
graph or on a reconstruction from the CT scan. In 40 cases
the distance from carina was impossible to measure. The
localization (side and lobe) of the lesion was registered
from the CT scan. In cases of multiple lesions, the sam-
pled lesions were registered. The cases were categorized as
indeterminate when it was impossible to decide which
lesion that had been sampled.
Malignant lung disease was defined as positive histologi-
cal or cytological results or certain malignant disease after
clinical follow up. The Department of Pathology provided
a computer-based search in the registry of systemized
nomenclature of medicine (SNOMED) codes from all
bronchoscopies, ultrasound guided transthoracic needle
aspirations, CT guided samplings, and operations. Cells
suspicious of malignancy usually lead to further investiga-
tions and were not included in the definition of positive
diagnostic yield. The diagnostic yield in this study was
defined as sensitivity for cancer. The gold standard was
defined as histological proven malignant disease or clini-
cal malignant disease during follow up. Three sources of
information were used to avoid exclusion of patients withBMC Pulmonary Medicine 2008, 8:2 http://www.biomedcentral.com/1471-2466/8/2
Page 3 of 8
(page number not for citation purposes)
later proven malignant disease: 1) A computer based
search through patient journals for a later malignant diag-
nosis. 2) A review of the journals of all patients who died
before November 2005. 3) Follow up until November
2005 of all patients discharged with a diagnosis of an
uncertain pulmonary lesion.
The statistical analyses were performed in SPSS, using Chi
square tests for univariate analyses, multivariate logistic
regression to estimate the odds ratios and adjust for con-
founding, and McNemar's test to compare different sam-
pling techniques. The Regional Norwegian Ethical
Committee and the Norwegian Social Science Data Serv-
ice approved the study.
Results
The baseline characteristics of the patients are displayed in
Table 1. The first bronchoscopy provided a conclusive
diagnosis of malignant disease in 161 of the 363 patients
(44%). Two patients had cytological specimens suspi-
cious of cancer in the first bronchoscopy, with no other
sampling techniques to confirm the diagnosis. Almost
40% of the patients diagnosed with cancer these two years
were women.
The final diagnostic method and pathological classifica-
tion is shown in Table 2. Transthoracic sampling tech-
niques provided the diagnosis in 105/363 patients. Of the
transthoracic samples, 87 were obtained by CT guided
sampling, 12 by ultrasound guided sampling, two were
pleural biopsies, and four were pleural effusions (Table
2).
Table 3 presents the diagnostic yield of the different bron-
choscopic sampling techniques. The sampling techniques
performed were biopsy (201/363), TBNA (191/363),
brushing (187/363), SVL (72/363), and aspiration of
fluid from the entire procedure (356/363). Biopsy consist-
ently gave the highest diagnostic yield with the possible
exception in the case of lesions smaller than 2 cm. In uni-
variate analyses endobronchial visibility, tumor size, and
distance from carina were predictors of a higher diagnos-
tic yield (Table 3). The overall sensitivity for cancer
increased from 16.7% in non-visible lesions, to 34.4% for
compression, constriction or submucosal disease, and fur-
ther to 76.6% in visible lesions (χ2: p < 0.001).
In non visible lesions the diagnostic yield using a C-arm
fluoroscope was 17/48 (35.4%) compared to 4/83 (4.8%)
Table 2: The diagnostic method and final diagnosis of 363 cases 
with malignant lung disease.
n%
Final diagnostic method
First bronchoscopy* 163 44.9
Repeated bronchoscopy 28 7.7
Transthoracic sampling 105 28.9
Mediastinoscopy 2 0.6
Operation, autopsy and open lung biopsy 11 3.0
Sampling from other organs than the lung 15 4.1
Clinical diagnosis of cancer 17 4.7
Malignant diagnosis obtained before bronchoscopy 22 6.1
Pathology
Small cell lung cancer 53 14.6
Adenocarcinoma 100 27.5
Squamous cell carcinoma 66 18.2
Large cell carcinoma 10 2.8
Non classifiable non small cell lung cancer. 82 22.6
Metastasis to the lung 21 5.8
Other cancer in the lung# 14 3.9
Only clinical diagnosis 17 4.7
* 2 patients diagnosed with uncertain pathology.
#Other cancer in the lung: Carcinoid tumor:6, Lymphoma:5, 
Mesothelioma:2,
Neuroendocrine tumor:1.
Table 1: Baseline characteristics of 363 cases
n%
Sex
Male 221 60.9
Female 142 39.1
Age (years)
< 59 87 24.0
59–67 92 25.3
68–74 90 24.8
> 74 94 25.9
Size*
<= 2 cm 41 11.3
2–3 cm 62 17.1
3–4 cm 53 14.6
> 4 cm 207 57.0
Distance from carina#
<= 5 cm 144 39.7
> 5 cm 179 49.3
Indeterminate 40 11.0
Endobronchial visibility
Non visible lesion 132 36.4
Constriction, compression or submucosal lesion 90 24.8
Visible lesion 141 38.8
Localization
Left upper lobe without lingula 75 20.7
Left lingula 10 2.8
Left lower lobe 53 14.6
Right upper lobe 88 24.2
Right middle lobe 19 5.2
Right lower lobe 73 20.1
Mediastinum 30 8.3
Indeterminate 15 4.1
*Size was measured on axial Ct thorax, only chest radiograph available 
in 5 cases.
#Distance from carina is measured as the distance from carina to the 
lesion on the chest radiograph, front projection.BMC Pulmonary Medicine 2008, 8:2 http://www.biomedcentral.com/1471-2466/8/2
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without a C-arm fluoroscope (χ2: p < 0.001), data not
shown in Table 3.
Table 4 presents predictors of diagnostic yield for each
sampling technique in a multivariate analysis after adjust-
ment for age, sex, lobe, endobronchial visibility, size and
distance from carina. The adjusted odds ratio (OR) for a
positive diagnostic result, was 2.6 (1.3–5.2) for constric-
tion, compression or suspected submucosal changes and
17.0 (8.5–34.0) for visible lesions, compared to non visi-
ble lesions. Endobronchial visibility was a significant pre-
dictor for a higher diagnostic yield in all sampling
techniques. Larger tumor size predicted an overall higher
diagnostic yield, but was statistically significant only for
Table 4: Predictors of a higher diagnostic yield. Odds ratio (95%CI) in multivariate analysis.
Biopsy (n = 201) TBNA (n = 191) Brushing (n = 187) Aspiration (n = 356) All (n = 363)
Endobronchial visibility ** ** * ** **
Non-visible lesion 1 1 1 1 1
Compression/constriction 2.4 (0.8–7.0) 1.2 (0.3–4.4) 0.4 (0.1–1.5) 0.8 (0.1–4.6) 2.6 (1.3–5.2)
Visible lesion 10.8 (3.8–30.7) 5.0 (1.4–17.5) 3.1 (1.1–8.3) 6.4 (1.9–20.9) 17.0 (8.5–34.0)
Tumor size * *
<= 2 cm 1 1 1 1 1
2–3 cm 7.9 (1.4–45.1) 0.8 (0.2–4.0) 1.1 (0.2–7.3) 2.2 (0.4–12.7) 2.5 (0.8–7.9)
3–4 cm 9.4 (1.7–52.2) 3.1 (0.6–15.3) 2.8 (0.5–17.0) 2.1 (0.3–13.6) 6.7 (2.1–21.8)
> 4 cm 6.7 (1.5–30.6) 2.0 (0.5–7.6) 2.0 (0.4–10.9) 1.0 (0.2–5.4) 3.8 (1.3–10.7)
Odds ratio adjusted for age, sex, lobe and distance from carina. TBNA = Transbronchial needle aspiration.
* Likelihood ratio: p < 0.05. ** Likelihood ratio: p < 0.001.
Table 3: Diagnostic yield of different sampling techniques
Biopsy (n = 201) TBNA (n = 191) Brushing (n = 187) SVL (n = 72) Aspiration (n = 356) All (n = 363)
Overall diagnostic yield 122/201 (60.7) 78/191 (40.8) 43/187 (23.0) 5/72 (6.9) 29/356 (8.1) 161/363 (44.4)
Endobronchial visibility ** ** ** ** **
Non visible lesion 9/36 (25.0) 4/21 (19.0) 13/68 (16.0) 3/46 (6.5) 5/130 (3.8) 22/132 (16.7)
Constriction/compression 22/48 (45.8) 17/69 (24.6) 5/49 (10.2) 1/11 (9.1) 2/88 (2.3) 31/90 (34.4)
Visible lesion 91/117 (77.8) 57/101 (56.4) 25/57 (43.9) 1/15 (6.7) 22/138 (15.9) 108/141 (76.6)
Tumor size * **
<= 2 cm 3/13 (23.1) 4/16 (25.0) 2/19 (10.5) 0/13 (0.0) 2/41 (4.9) 7/41 (17.1)
> 2 cm and <= 3 cm 15/24 (62.5) 6/18 (25.0) 4/35 (11.4) 0/19 (0.0) 6/59 (10.2) 20/62 (32.3)
> 3 cm and <= 4 cm 19/35 (54.3) 12/24 (50.0) 8/31 (25.8) 1/13 (7.7) 4/51 (7.8) 25/53 (47.2)
> 4 cm 85/129 (65.9) 56/127 (44.1) 29/102 (28.4) 4/27 (14.8) 17/205 (8.3) 109/207 (52.7)
Distance to carina ** *
<= 5 cm 59/86 (68.6) 40/93 (43.0) 23/68 (33.8) 0/12 (0.0) 13/142 (9.2) 78/144 (54.2)
> 5 cm 44/88 (50.0) 26/74 (35.1) 17/102 (16.7) 3/52 (5.8) 12/165 (6.8) 62/179 (34.6)
Indeterminate 19/27 (70.4) 12/24 (50.0) 3/17 (17.6) 2/8 (25.0) 4/37 (10.8) 21/40 (52.5)
Side
Left 49/80 (61.3) 26/75 (34.7) 20/80 (25.0) 4/27 (14.8) 14/147 (9.5) 62/151 (41.1)
Right 68/115 (59.1) 46/106 (43.4) 22/103 (21.4) 1/42 (2.4) 14/195 (7.2) 92/198 (46.5)
Indeterminate 5/6 (83.3) 6/10 (60.0) 1/4 (25.0) 0/3 (0.0) 1/14 (7.1) 7/14 (50.0)
Lobe
Upper lobe without lingula 47/92 (51.1) 29/91 (31.9) 20/92 (21.7) 3/27 (11.1) 15/162 (9.3) 68/164 (41.5)
Middle lobe/lingula 8/13 (61.5) 6/14 (42.9) 6/18 (33.3) 0/9 (0.0) 0/27 (0.0) 11/29 (37.9)
Lower lobe 50/74 (67.6) 29/58 (50.0) 13/60 (21.7) 2/30 (6.7) 11/124 (8.9) 61/127 (48.0)
Mediastinum 8/11 (72.7) 7/18 (38.9) 2/13 (15.4) 0/5 (0.0) 0/30 (0.0) 12/30 (40.0)
Indeterminate 9/11 (81.8) 7/10 (70) 2/4 (50.0) 0/1 (0.0) 3/13 (23.1) 9/13 (69.2)
*p < 0.05. **p < 0.001
Data are presented as number of positive samples/all samples (%). Statistical analysis: χ2.
TBNA = Transbronchial needle aspiration. SVL = Small volume lavage.BMC Pulmonary Medicine 2008, 8:2 http://www.biomedcentral.com/1471-2466/8/2
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biopsies. In the multivariate analyses, distance from car-
ina and localization of the lesion did not predict the diag-
nostic yield.
Different pairs of sampling techniques were compared
(Table 5). The sample size was not large enough to com-
pare endobronchial visibility in three categories. There-
fore non-visible lesions, compression, constriction, or
suspected submucosal changes were combined to one cat-
egory. In 86 patients with visible lesions, biopsy and
TBNA were performed with a combined diagnostic yield
of 83.7% (72/86, Table 5). In 38 of the 86 procedures,
brushing was performed in addition to biopsy and TBNA,
and in 85 of the procedures aspirations were also exam-
ined. Cytological examination of the brushings and aspi-
rations provided an increased diagnostic yield of one case
(NS). Compared to the combination of biopsy and TBNA
in these 86 procedures, seven cases would have been
missed without TBNA (p = 0.02), and 22 cases would have
been missed without biopsy (p < 0.001). The result in the
group with non-visible lesions, compression, constriction
or suspected submucosal changes was similar. In this
group, biopsy and TBNA was performed in 48 patients
with a combined diagnostic yield of 54.2% (Table 5). In
these procedures additional 47 aspirations and 25 brush-
ings were performed, which increased the diagnostic yield
by only one case (NS). The diagnostic yield with a combi-
nation of biopsy and TBNA was significantly higher than
with biopsy or TBNA alone.
Discussion
Endobronchial visibility and tumor size were the predic-
tors of diagnostic yield in bronchoscopies of patients with
malignant disease in this study. The diagnostic yield was
16.7% in procedures with non-visible lesions, 34.4% in
procedures with compression, constriction or suspected
submucosal changes, and 76.6% in procedures with
endobronchial visible lesions. The combination of biopsy
and TBNA had the highest diagnostic yield both in visible
lesions and in the combined group of non-visible lesions,
constriction, compression, or suspected submucosal
changes. Biopsy and TBNA together was significant better
than either technique alone.
There are some methodological issues to consider.
The main strength of this study is that it reflects the diag-
nostic value of bronchoscopy in a regular clinical practice.
For many operative procedures, an important factor is the
skill of the operator. The current study did not have the
power to examine diagnostic yield by operator. However,
the large number of operators partly reflects the large
number of patients seen with lung cancer, at our centre.
The results of this study should be comparable to centres
that include trainees and where each doctor performs
approximately thirty bronchoscopies per year.
Patient selection bias is a problem in studies of diagnostic
yield in bronchoscopy. Haukeland University Hospital is
the only centre for diagnosing lung cancer in Hordaland
County and some smaller surrounding municipalities.
Thus all patients from surrounding area would be
included. The follow up time to December 2005 with
inclusion of clinical cancer were important factors to
ensure inclusion of all cancers present among those exam-
ined in 2003/04.
Another selection bias pertains to the choice of sampling
methods. In our centre, the choice of sampling method is
left to the judgement of the examiner. Thus, although in
most bronchoscopies more than one sampling method
was employed, for example biopsy and TBNA, rarely all
five available techniques were used. In many procedures
there is an urge to use the least amount of material and
Table 5: Diagnostic yield of different combinations of sampling techniques
The result of the first two 
sampling techniques in the 
combination
The result of all sampling 
techniques performed
The result of the first 
sampling technique (1)
The result of the second 
sampling technique (2)
DY (%) DY (%) p DY (%) p DY (%) p
Non-visible lesion/compression or constriction:
Biopsy(1) and TBNA(2) 26/48 (54.2) 27/48 (56.3) NS 20/48 (41.7) 0.03 16/48 (33.3) 0.002
Biopsy(1) and Brushing(2) 18/42 (42.9) 20/42 (47.6) NS 14/42 (33.3) NS 9/42 (21.4) 0.004
TBNA(1) and Brushing(2) 16/51 (31.4) 21/51 (41.2) 0.06 11/51 (21.6) 0.06 10/51 (19.6) 0.03
Endobronchial visible lesion:
Biopsy(1) and TBNA(2) 72/86 (83.7) 73/86 (84.9) NS 65/86 (75.6) 0.02 50/86 (58.1) < 0.001
Biopsy(1) and Brushing(2) 37/46 (80.4) 39/46 (84.8) NS 34/46 (73.9) NS 23/46 (50.0) < 0.001
TBNA(1) and Brushing(2) 30/47 (63.8) 39/47 (83.0) 0.004 27/47 (57.4) NS 22/47 (46.8) 0.008
Data are presented as number of positive samples/all samples (%). Statistical analysis: McNemar's test. DY = Diagnostic Yield. All results are 
compared with the diagnostic yield of the respective combination of the two sampling techniques.BMC Pulmonary Medicine 2008, 8:2 http://www.biomedcentral.com/1471-2466/8/2
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time necessary, in order to avoid complications and dis-
comfort for the patients. Thus, an operator who feels to
have obtained an adequate sample may terminate the pro-
cedure without all techniques being employed. On the
other hand, some sampling techniques may be dropped if
complications arise, or the tumor seems impossible to
reach. Clearly this is a weakness in the current study, when
comparing the different sampling methods. However, the
current study reflects how bronchoscopies are normally
performed. In studies where all possible techniques are
used, there may be a selection bias in that patients where
the procedure is terminated prior to full sampling, for
instance due to complications, are excluded from the
study. This bias would likely inflate the results from stud-
ies in which only patients having undergone all proce-
dures are included.
Previous studies have categorized "compression, constric-
tion or suspected submucosal changes" either with visible
lesions or with non-visible lesions. Some studies have
included these as non specific findings [12,30], thus
increasing the diagnostic yield of peripheral lesions.
Other studies have classified the findings as submucosal-
peribronchial disease [31,32], decreasing the diagnostic
yield of visible lesions. We have classified this group as a
separate category. The finding that these lesions show a
diagnostic yield intermediate between visible and non-
visible supports our choice of classification. However, for
the analyses in table 5, sample size dictated that non-visi-
ble lesions be grouped with "compression, constriction or
suspected submucosal changes". As TBNA and biopsy
were more often used for the later category, and brushings
more often for non-visible lesions, there could be a ten-
dency for the results of TBNA to appear better in the com-
bined category.
The overall diagnostic yield of 77% in visible lesions, is
similar to previously reported results [7,21,25,30,31]. The
overall diagnostic yield of 17% in non visible lesions is
lower than in some studies [3,5-15], but higher than the
yield reported in a Scottish multi-centre study (9%) [30].
The individual diagnostic yield of biopsy, brushing or
TBNA from visible lesions were similar to previous
reported studies [18,21,28,29]. SVL and aspiration had
lower diagnostic yields for visible and non visible lesions,
compared with other studies [21,25,33]. Studies with
bronchoalveolar lavage have had a higher diagnostic
yield, possibly due to higher fluid volume [22,23]. The
low diagnostic yield might also be explained by the proce-
dure of taking a small sample of 10–20 ml from the fluid
aspirated and the lack of wedging the bronchoscope into
the affected bronchus. Although there are relatively few
prospective trials, they tend to report a higher diagnostic
yield than retrospective trials, which may be due to the
benefits of planning [20,28]. Studies from highly special-
ized centres or from selected procedures with all sampling
techniques, have a higher diagnostic yield compared to
the current study [5,8,13].
The C-arm fluoroscope increased the diagnostic yield
from 5% to 35%. The rate of fluoroscopy in the current
study was low, mainly because the C-arm fluoroscope was
operated by radiographers who were not always available.
The current study was not powered to examine differences
in diagnostic yield between procedures with and without
the C-arm fluoroscope. However, this study suggests a sig-
nificant benefit from using the fluoroscope.
Several studies have examined predictors for a higher
diagnostic yield, but only in univariate analysis [9-11,13-
16,18,20]. Significant predictors found have been size
[10,14-16,20], location [9-11], and endobronchial visibil-
ity [18]. In the current study, endobronchial visibility and
tumor size prevailed as significant predictors when several
potential predictors were examined together. Stratified on
each sampling technique, the effect of size was significant
only for biopsy. Both brushing and TBNA gave better
results in larger lesions, but the results were not statisti-
cally significant. This could indicate that sample size was
too small to show the effect of size on these sampling
methods. However, brushings might be sampled from a
wider area than biopsy, and the size of the lesion might be
less important for this method.
Knowing the diagnostic yield of each sampling technique
is important for choosing the optimal combination
[11,32-34]. In the current study biopsy was the most
important sampling technique in patients with and with-
out visible lesions. Addition of TBNA or brushing
increased the diagnostic yield of biopsy, but three sam-
pling techniques were not significantly better than two.
Biopsy and TBNA had the highest combined diagnostic
yield but the results must be interpreted cautiously. The
most important reasons that the result could be biased
was the retrospective nature of the study, because non vis-
ible lesions had to be categorized together with compres-
sion and constriction, and because of the low number of
biopsy, brushing and TBNA. Although brushings did not
prove significant additional benefit, too few procedures
included brushings for the matter to be settled. However,
the value of SVL and aspiration in addition to the other
techniques seemed too small to warrant the effort. While
BTS guidelines presently recommend a combination of
biopsy, brushing, and washing, these data suggest that the
combination of biopsy and TBNA may be superior for vis-
ible and non-visible lesions.BMC Pulmonary Medicine 2008, 8:2 http://www.biomedcentral.com/1471-2466/8/2
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Conclusion
This study evaluated predictors of diagnostic yield of
bronchoscopy reflecting clinical real life. Endobronchial
visible lesion and larger tumor size predicted a higher
diagnostic yield. The diagnostic yield was comparable
with previous studies for visible lesions but was lower
than in many of the previous studies for non-visible
lesions.
BTS guideline recommended biopsy, brushing and wash-
ing for visible lesions. This study has shown that biopsy
and TBNA might be better. In the combined group of
compression, constriction, suspected submucosal disease
and non visible lesions, biopsy and TBNA was better than
each sampling technique alone, however this study did
not have sufficient power to determine whether brushing
should be performed or not. These groups should be fur-
ther investigated to find the optimal combination of sam-
pling techniques and a cost effectiveness analysis could be
performed. Washings were performed in almost all proce-
dures and did not increase the diagnostic yield signifi-
cantly in any groups.
Abbreviations
BTS = British Thoracic Society, CI = confidence interval,
CT = computer tomography, OR = odds ratio, SD = stand-
ard deviation, SNOMED = systemized nomenclature of
medicine, SVL = small volume lavage, TBNA = transbron-
chial needle aspiration.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
TME and KR read the bronchoscopy reports and registered
the information provided, viewed the chest radiographs
and the CT scans, implemented the information from the
pathological department, performed the statistical analy-
sis, and wrote the manuscript.
JH and AHA participated in the design of the study, and
reviewed the manuscript thoroughly.
FL provided all the information from the pathological
department, was part of the planning of the study, and
reviewed the manuscript thoroughly.
Acknowledgements
The study was founded by a one year grant for KR from Helse Vest and by 
a grant from Helse Sunnmore.
References
1. Cancer registry of Norway   [http://www.kreftregisteret.no].
(Nov 2006).
2. Honeybourne D, Babb J, Bowie P, Brewin A, Fraise A, Garrard C,
Harvey J, Lewis R, Neumann C, Wathen CG, Williams T: British
Thoracic Society guidelines on diagnostic flexible bronchos-
copy.  Thorax 2001, 56:I1-I21.
3. Schreiber G, McCrory DC: Performance characteristics of dif-
ferent modalities for diagnosis of suspected lung cancer:
Summary of published evidence.  Chest 2003, 123:115S-128S.
4. Charig MJ, Phillips AJ: CT-guided cutting needle biopsy of lung
lesions – Safety and efficacy of an out-patient service.  Clinical
Radiology 2000, 55:964-969.
5. Gasparini S, Ferretti M, Secchi EB, Baldelli S, Zuccatosta L, Gusella P:
Integration of transbronchial and percutaneous approach in
the diagnosis of peripheral pulmonary nodules or masses.
Experience with 1,027 consecutive cases.  Chest 1995,
108:131-137.
6. Hattori S, Matsuda M, NISHIHAR H, Horai T: Early diagnosis of
small peripheral lung cancer – Cytologic diagnosis of very
fresh cancer cells obtained by TV-brushing technique.  Acta
Cytologica 1971, 15:460-467.
7. Lam WK, So SY, Hsu C: Fiberoptic bronchoscopy in the diagno-
sis of bronchial cancer: Comparison of washings, brushings
and biopsies in central and peripheral tumors.  Clinical Oncology
1983, 9:35-42.
8. Torrington KG, Kern JD: The utility of fiberoptic bronchoscopy
in the evaluation of the solitary pulmonary nodule.  Chest
1993, 104:1021-1024.
9. Wallace JM, Deutsch AL: Flexible fiberoptic bronchoscopy and
percutaneous needle lung aspiration for evaluating the soli-
tary pulmonary nodule.  Chest 1982, 81:665-671.
10. Baaklini WA, Reinoso MA, Gorin AB, Sharafkanch A, Manian P: Diag-
nostic yield of fiberoptic bronchoscopy in evaluating solitary
pulmonary nodules.  Chest 2000, 117:1049-1054.
11. Chechani V: Bronchoscopic diagnosis of solitary pulmonary
nodules and lung masses in the absence of endobronchial
abnormality.  Chest 1996, 109:620-625.
12. Estarriol MH, Goday MR, Sanchez MV, Padro XB, Sot MTC, Quetglas
FS: Bronchoscopic lung biopsy with fluoroscopy to study 164
localized pulmonary lesions.  Archivos de Bronconeumologia 2004,
40:483-488.
13. Naidich DP, Sussman R, Kutcher WL, Aranda CP, Garay SM, Ettenger
NA: Solitary pulmonary nodules. CT -bronchoscopic correla-
tion.  Chest 1988, 93:595-598.
14. Radke JR, Conway WA, Eyler WR, Kvale PA: Diagnostic accuracy
in peripheral lung lesions. Factors predicting success with
flexible bronchoscopy.  Chest 1979, 76:176-179.
15. Reichenberger F, Weber J, Tamm M, Bolliger CT, Dalquen P, Perru-
choud AP, Soler M: The value of transbronchial needle aspira-
tion in the diagnosis of peripheral pulmonary lesions.  Chest
1999, 116:704-708.
16. Stringfield JT, Markowitz DJ, Bentz RR, Welch MH, Weg JG: Effect
of tumor size and location on diagnosis by fiberoptic bron-
choscopy.  Chest 1977, 72:474-476.
17. Aristizabal JF, Young KR, Nath H: Can chest CT decrease the use
of preoperative bronchoscopy in the evaluation of suspected
bronchogenic carcinoma?  Chest 1998, 113:1244-1249.
18. Castella J, Buj J, Puzo C, Anton PA, Burgues C: Diagnosis and stag-
ing of bronchogenic carcinoma by transtracheal and trans-
bronchial needle aspiration.  Annals of Oncology 1995, 6(Suppl
3):s21-s24.
19. Pilotti S, Rilke F, Gribaudi G, Spinelli P: Cytologic diagnosis of pul-
monary carcinoma on bronchoscopic brushing material.  Acta
Cytologica 1982, 26:655-660.
20. Bilaceroglu S, Kumcuoglu Z, Alper H, Osma E, Cagirici U, Gunel O,
Bayol U, Celikten E, Perim K, Kose T: CT bronchus sign-guided
bronchoscopic multiple diagnostic: Procedures in carcino-
matous solitary pulmonary nodules and masses.  Respiration
1998, 65:49-55.
21. Kvale PA, Bode FR, Kini S: Diagnostic accuracy in lung cancer;
Comparison of techniques used in association with flexible
fiberoptic bronchoscopy.  Chest 1976, 69:752-757.
22. Debeljak A, Mermolja M, Sorli J, Zupancic M, Zorman M, Remskar J:
Bronchoalveolar lavage in the diagnosis of peripheral pri-
mary and secondary malignant lung tumors.  Respiration 1994,
61:226-230.
23. de Gracia J, Bravo C, Miravitlles M, Tallada N, Orriols R, Bellmunt J,
Vendrell M, Morell F: Diagnostic value of bronchoalveolar lav-
age in peripheral lung cancer.  American Review of Respiratory Dis-
ease 1993, 147:649-652.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pulmonary Medicine 2008, 8:2 http://www.biomedcentral.com/1471-2466/8/2
Page 8 of 8
(page number not for citation purposes)
24. Gay PC, Brutinel WM: Transbronchial needle aspiration in the
practice of bronchoscopy.  Mayo Clinic Proceedings 1989,
64:158-162.
25. Mak VHF, Johnston IDA, Hetzel MR, Grubb C: Value of washings
and brushings at fiberoptic bronchoscopy in the diagnosis of
lung cancer.  Thorax 1990, 45:373-376.
26. Mori K, Yanase N, Kaneko M, Ono R, Ikeda S: Diagnosis of periph-
eral lung cancer in cases of tumors 2 cm or less in size.  Chest
1989, 95:304-308.
27. Pirozynski M: Bronchoalveolar lavage in the diagnosis of
peripheral, primary lung cancer.  Chest 1992, 102:372-374.
28. Popp W, Rauscher H, Ritschka L, Redtenbacher S, Zwick H, Dutz W:
Diagnostic sensitivity of different techniques in the diagnosis
of lung tumors with flexible fiberoptic bronchoscope. Com-
parison of brush biopsy, imprint cytology of forceps biopsy,
and histology of forceps biopsy.  Cancer 1991, 67:72-75.
29. Zavala DC: Diagnostic fiberoptic bronchoscopy: Techniques
and results of biopsy in 600 patients.  Chest 1975, 68:12-19.
30. Mclean AN, Semple PD, Franklin DH, Petrie G, Millar EA, Douglas JG:
The Scottish multi-centre prospective study of bronchos-
copy for bronchial carcinoma and suggested audit standards.
Respiratory Medicine 1998, 92:1110-1115.
31. Kacar N, Tuksavul F, Edipoglu O, Ermete S, Guclu SZ: Effectiveness
of transbronchial needle aspiration in the diagnosis of exo-
phytic endobronchial lesions and submucosal/peribronchial
diseases of the lung.  Lung Cancer 2005, 50:221-226.
32. Govert JA, Kopita JM, Matchar D, Kussin PS, Samuelson WM: Cost-
effectiveness of collecting routine cytologic specimens dur-
ing fiberoptic bronchoscopy for endoscopically visible lung
tumor.  Chest 1996, 109:451-456.
33. van der Drift MA, van der Wilt GJ, Thunnissen FBJM, Janssen JP: A
prospective study of the timing and cost-effectiveness of
bronchial washing during bronchoscopy for pulmonary
malignant tumors.  Chest 2005, 128:394-400.
34. Karahalli E, Yilmaz A, Turker H, Ozvaran K: Usefulness of various
diagnostic techniques during fiberoptic bronchoscopy for
endoscopically visible lung cancer: Should cytologic exami-
nations be performed routinely?  Respiration 2001, 68:611-614.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2466/8/2/prepub